在乙型肝炎病毒相关的肝细胞癌中,CTNNB1突变状态和瘤表型之间的相关性
Yoon Jung Hwang1,2, Yangkyu Lee1,3, Su Jong Yu4
1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Histopathology
|November 11, 2024
概括
CTNNB1突变发生在13%的与乙型肝炎病毒相关的肝细胞癌 (HCC) 中. 这些突变与特定的谷氨酸合成酶和核β-catenin表达模式以及独特的瘤形态相关.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题.
- CTNNB1突变在HCC中很常见,但在与乙型肝炎病毒 (HBV) 相关的病例和亚洲人群中不太常见.
- 了解与HBV相关的HCC中CTNNB1突变模式对于向治疗至关重要.
研究的目的:
- 研究与HBV相关的HCC中CTNNB1突变的患病率和类型.
- 为了将CTNNB1分子状态与组织形态学和免疫组织化学特征相关联.
- 分析CTNNB1突变与谷氨胺合成酶 (GS) 和核β-catenin表达之间的关联.
主要方法:
- 分析了108例以前未接受过治疗的,手术切除的与HBV相关的HCC病例.
- 针对CTNNB1第3,7和8个异构的有针对性的测序.
- 突变数据与GS表达,核β-catenin和瘤形态的相关性.
主要成果:
- 在13%的与HBV相关的HCC中发现了CTNNB1突变,主要在第3个表原 (D32-S37,T41,S45).
- 突变与扩散强的GS表达 (78.6%),核β-catenin表达 (64.3%) 和经典CTNNB1形态 (57%) 强烈相关.
- 编程死亡连接体1 (PD-L1) 表达在具有经典CTNNB1形态的HCC中较低.
结论:
- 在韩国队列中,CTNNB1突变存在于13%的HBV相关HCC中.
- 这些突变与特定的分子标记 (GS,核β-catenin) 和组织形态特征有关.
- 这些发现有助于理解与HBV相关的HCC的分子格局.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


